Clinical trial
STeroid Options for RA Management (STORM-RA): Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares: A Pragmatic Randomized Clinical Trial
NCT07245732 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- STeroid Options for RA Management (STORM-RA): Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares: A Pragmatic Randomized Clinical Trial
- Lead sponsor
- Sunnybrook Health Sciences Centre
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- April 30, 2026
- Completion date
- July 31, 2029
- Enrollment
- 220 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis (ra)